CERo Therapeutics Warrants
CEROW
CEROW was delisted on the 30th of October, 2025.
1 hedge funds and large institutions have $22 invested in CERo Therapeutics Warrants in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.
95% less funds holding
Funds holding: 22 → 1 (-21)
100% less capital invested
Capital invested by funds: $38.1K → $22 (-$38.1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 21
3,090.99% less ownership
Funds ownership: 3,093.71% → 2.72% (-3,091%)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
-$6.14K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$5.33K |
| 3 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$4.99K |
| 4 |
SCM
Saba Capital Management
New York
|
-$4.26K |
| 5 |
LA
Linden Advisors
New York
|
-$3.6K |
CEROW Hedge Fund Activity: Q4 2025 in Review
1 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2025, worth a combined $22 — down 100% from $38.1K a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of CEROW and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Clear Street, exiting entirely with an estimated $6.14K sold.
- 1 institutional investor held CERo Therapeutics Warrants (CEROW) as of Q4 2025, down from 22 in Q3 2025.
- Funds reported $22 of CERo Therapeutics Warrants stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new CERo Therapeutics Warrants positions in Q4 2025 and 21 closed out, a net change of -21 holders.
- The largest CERo Therapeutics Warrants seller in Q4 2025 was Clear Street, an estimated $6.14K sold.
Based on aggregated 13F filings for Q4 2025.